DRL launches nystatin and triamcinolone acetonide cream in USA

Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream USP, in the United States market which has been approved by the USFDA. The drug is the generic equivalent of nystatin and triamcinolone acetonide cream, USP 1,00,000 units/g-0.1 per cent manufactured by Taro Pharmaceuticals USA Inc. According to market estimates – for the 12-month period ending October 2016, the generic had US sales of around USD 119 million.

Company Profile : Dr Reddys Laboratories Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*